English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background:  The maximum standardized uptake values (SUVmax) derived from  18 F-fluorodeoxy-glucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) have some well-known shortcomings in predicting treatment response and prognosis in oncology. The standardized SUVmax with an appropriate reference background may overcome this problem in some instances. This study explored the prognostic value of the tumor-to-liver SUVmax ratio (SUV TLR ) and the tumor-to-blood pool SUVmax ratio (SUV TBR ) in predicting the objective response (OR) and overall survival (OS) in patients with locally advanced esophageal cancer after concurrent chemoradiotherapy (CCRT).   Methods:  We retrospectively analyzed 128 newly diagnosed esophageal squamous cell carcinoma (ESCC) patients who were treated with CCRT. The SUVmax of primary tumor, SUV TLR , SUV TBR  and clinicopathologic features data were analyzed. Univariate and multivariate analyses were used to determine the predictors of tumor response. Survival analysis was performed using the Kaplan–Meier method and Cox proportional hazards model.   Results:  Receiver operating characteristic (ROC) curve analysis demonstrated that SUV TLR  was superior to SUVmax and SUV TBR  in predicting treatment response. Univariate and multivariate analyses revealed that advanced tumor stage (hazard ratio [HR] = 9.67; 95% CI: 1.15-81.28;  P  = 0.037) and high SUV TLR  (HR = 21.92; 95% CI: 2.26-212.96;  P  = 0.008) were independent predictors of poor treatment response. Cox regression analysis showed that good clinical tumor response ( p  < 0.014, HR =0.501; 95% CI: 0.288–0.871) was a favorable independent predictive factor for OS, while an advanced tumor stage (p = 0.018, HR = 1.796; 95% CI: 1.107-2.915) and a high SUV TLR  ( p  < 0.002, HR = 2.660; 95% CI: 1.425–4.967) were prognostic factors for poor OS. The median OS of patients in the low SUV TLR  and high SUV TLR  groups was 13.47 vs. 19.30 months, respectively.   Conclusions:  PET-derived SUV TLR  is superior to tumor SUVmax and SUV TBR  in predicting treatment response and overall survival in patients with ESCC undergoing CCRT. High SUV TLR  was an independent predictor of poor treatment response and shorter overall survival.

frontiers in oncology

The PET-Derived Tumor-to-Liver Standard Uptake Ratio (SUVTLR) Is Superior to Tumor SUVmax in Predicting Tumor Response and Survival After Chemoradiotherapy in Patients With Locally Advanced Esophageal Cancer